drugset / Trial / NCT00838799

Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain

NCT00838799

Phase 2 Completed 458 enrolled Forest Laboratories Gedeon Richter Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to evaluate the safety and efficacy of RGH-896 in patients with diabetic peripheral neuropathic pain.

Timeline

Start
2009-02
Primary completion
2010-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 100 mg
Subject Radiprodil Small molecule 15 mg
Subject Radiprodil Small molecule 30 mg
Subject Radiprodil Small molecule 45 mg